About Volumetric Bio
Volumetric Bio is a company based in Houston (United States) founded in 2018 by Bagrat Grigoryan and Jordan Miller was acquired by 3D Systems in October 2021. Volumetric Bio has raised $125 thousand across 1 funding round from investors including 3D Systems and Y Combinator. Volumetric Bio operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Houston, United States
- Founders Bagrat Grigoryan, Jordan Miller
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$125 K (USD)
in 1 rounds
-
Latest Funding Round
$125 K (USD), Seed
Mar 17, 2020
-
Investors
3D Systems
& 1 more
-
Employee Count
Not available
-
Acquired by
3D Systems
(Oct 27, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Volumetric Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Volumetric Bio
Volumetric Bio has successfully raised a total of $125K through 1 strategic funding round. The most recent funding activity was a Seed round of $125 thousand completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Volumetric Bio
Volumetric Bio has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include 3D Systems and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
Provider of solid imaging solutions
|
Locked | Locked | Locked |
Investor details for Volumetric Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Volumetric Bio
Investment portfolio details for Volumetric Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Volumetric Bio
Detailed financials for Volumetric Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Volumetric Bio Comparisons
Peer comparison for Volumetric Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Volumetric Bio
Volumetric Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Volumetric Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Volumetric Bio
Complete news archive for Volumetric Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Volumetric Bio
Volumetric Bio was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Volumetric Bio is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Volumetric Bio is a funded company, having raised a total of $125K across 1 funding round to date.
Volumetric was founded in 2018 in Houston, United States, and operates in the biofabrication sector. A light-based bioprinting platform has been developed by the company for applications in life sciences, drug discovery, and medical devices. Custom bioprinters, such as the Lumen X model, are offered alongside reagents including 6000 Da polyethylene glycol, LAP photoinitiator, carbohydrate glass, and Gel MA. Bio-inks are also provided to support these technologies.
Volumetric Bio's top competitors include Sutro Biopharma, Nuclera Nucleics and Avidity Biosciences.
Volumetric Bio has 2 investors. Key investors include 3D Systems, and Y Combinator.